← Open Payments lookup

DEREK KABASAWA: Open Payments

NPI 1710611884 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,910 in 113 payments from 15 companies in 2025. Trend: 2023 $1,613 · 2024 $1,356 · 2025 $1,910

Food & beverage: $1,910
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.17$296
Teva Pharmaceuticals USA, Inc.20$293
Vanda Pharmaceuticals Inc.14$240
Alkermes, Inc.11$209
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$198
Janssen Pharmaceuticals, Inc11$152
Neurocrine BioSciences, Inc.8$146
Axsome Therapeutics, Inc.4$70
Supernus Pharmaceuticals, Inc.4$65
Noven Therapeutics, LLC4$61

Products named: REXULTI, FANAPT, CAPLYTA, UZEDY, ARISTADA, INGREZZA, AUSTEDO XR, INVEGA SUSTENNA.

Industry payments across OK — which companies pay providers there.